Exane Derivatives’s NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) NBG Stock Holding History

Exane Derivatives’s Portfolio NBG Stock Details NBG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2	Closed	-$1	–	592
2015 Q3	$1	Sell	2 -107,541	-100%	-$87.5K	﹤0.01%	531
2015 Q2	$113K	Sell	107,543 -222,224	-67%	-$287K	0.01%	246
2015 Q1	$422K	Sell	329,767 -476,204	-59%	-$698K	0.05%	155
2014 Q4	$1.44M	Buy	+805,971	New	+$1.89M	0.2%	82

Exane Derivatives's NBG Position: Q4 2015 in Review

Exane Derivatives sold out of NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) (NBG) in Q4 2015, closing a stake of 2 shares — an estimated $1 sold.

Exane Derivatives first reported a position in NBG in Q4 2014 and held it in 4 quarters. The position peaked at $1.44M in Q4 2014. 0 funds tracked by Wall St. Rank hold NBG as of Q4 2015.

Exane Derivatives reported no remaining NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) position as of Q4 2015 after selling out during the quarter.
Exane Derivatives sold 2 NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) shares in Q4 2015, an estimated $1.
Exane Derivatives first reported a position in NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) in Q4 2014 and held it in 4 quarters.
Exane Derivatives's NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) position peaked at $1.44M in Q4 2014.
0 funds tracked by Wall St. Rank held NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW) as of Q4 2015.

Based on Exane Derivatives's 13F filing for Q4 2015, filed 11 Feb 2016.